Inflammatory [ftcn]
activity [dora]
Antibodies, Anticardiolipin [aapp, imft]
tibolone [phsu, strd]
treatment [ftcn]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Aim [idcn]
Study [mnob]
To [qlco]
investigate [ftcn]
Inflammatory [ftcn]
activity [dora]
Antibodies, Anticardiolipin [aapp, imft]
ACT [topp]
tibolone [phsu, strd]
Administration [ocac]
twenty [orch, phsu]
Seven [qnco]
Health [idcn]
postmenopausal [tmco]
Women [popg]
included [ftcn]
Study [mnob]
divided [ftcn]
Two [qnco]
Group [idcn]
Women [popg]
Mean [qnco]
Age-Years [tmco]
Received [qlco]
tibolone [phsu, strd]
Dose [qnco]
mg day [qnco]
months [tmco]
untreated [fndg]
Control Group [grup]
N NOS [aapp, imft]
Mean [qnco]
Age-Years [tmco]
ACT [topp]
Isotype [aapp, imft]
C-reactive protein [aapp, imft]
baseline [bodm]
months [tmco]
treatment [ftcn]
ACT [topp]
Not [ftcn]
Change [ftcn]
tibolone [phsu, strd]
treatment [ftcn]
C-reactive protein [aapp, imft]
Increased [qnco]
month [tmco]
Compared [acty]
baseline [bodm]
Values [qlco]
Preliminary [tmco]
Data [idcn]
tibolone [phsu, strd]
Administration [ocac]
Not [ftcn]
Induce [ftcn]
Increase [ftcn]
ACT [topp]
This [euka]
Counterbalance [mnob]
influential [idcn]
C-reactive protein [aapp, imft]
[c] [qnco]
Science [ocdi]
Rights [qlco]
Reserve [acty]
